SCHEMBL7975692

SCHEMBL7975692

CCc1nc2c(O)cccc2n1C

nearest known ligand 0.49

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
TLR8 Q9NR97 1/20 0.49
MAPT P10636 5/20 0.42
KDM4E B2RXH2 3/20 0.42
GAA P10253 3/20 0.42
LMNA P02545 1/20 0.42
ACHE P22303 1/20 0.38
ALDH1A1 P00352 4/20 0.37
RAB9A P51151 3/20 0.37
NPC1 O15118 2/20 0.37
SMN1; SMN2 Q16637 2/20 0.37
METAP2 P50579 2/20 0.37
TLR7 Q9NYK1 1/20 0.37
KMT2A Q03164 4/20 0.36
MEN1 O00255 3/20 0.36
MAPK1 P28482 2/20 0.36
HTT P42858 2/20 0.36
ALOX15 P16050 1/20 0.36
TDP1 Q9NUW8 1/20 0.36
RECQL P46063 2/20 0.36
HPGD P15428 1/20 0.36

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL7965261 0.82 TLR8 (0.43) TLR8MAPTKDM4EGAALMNA
SCHEMBL9847092 0.81 TLR8 (0.48) TLR8GAARAB9ANPC1SMN1; SMN2
SCHEMBL12263310 0.79 MEN1 (0.43) MAPTGAALMNARAB9ANPC1
Ammonia Solution, Strong SCHEMBL4555054 0.79 TLR8 (0.49) TLR8LMNARAB9ANPC1SMN1; SMN2
SCHEMBL11923731 0.79 DPP4 (0.41) MAPTLMNARAB9ANPC1SMN1; SMN2
SCHEMBL12970516 0.79 GRM2 (0.47) LMNAALDH1A1RAB9ANPC1SMN1; SMN2
SCHEMBL7978871 0.78 AKT1 (0.42) TLR8KDM4EALDH1A1RAB9ANPC1
SCHEMBL6654439 0.78 TLR8 (0.46) TLR8MAPTKDM4EGAALMNA
SCHEMBL3194071 0.77 CYP1A2 (0.49) TLR8MAPTKDM4EGAALMNA
SCHEMBL23105499 0.76 PIK3CD (0.47) MAPTKDM4EALDH1A1RAB9ANPC1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 3 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-6194396-B1 ANTIALLERGENS; ANTIINFLAMMATION AGENTS; AUTOIMMUNE DISEASE; ANTISHOCK AGENTS; ANALGESICS; E.G., A 4 OR 7-PHENYLALKYLENE-OXYBENZIMIDAZOLE UNSUBSTITUTED OR SUBSTITUTED IN THE 1,2,3-POSITION WITH AN OXY, AMINO AND/OR THIO GROUP FUJISAWA PHARMACEUTICAL CO., LTD. (JP) 2001-02-27 US disclosed
US-6083961-A FOR PREVENTION AND/OR TREATMENT OF BRADYKININ OR ITS ANALOGUES MEDIATED DISEASES SUCH AS ALLERGY, INFLAMMATION, AUTOIMMUNE DISEASE, SHOCK, PAIN FUJISAWA PHARMACEUTICAL CO., LTD. (JP) 2000-07-04 US disclosed
EP-0774462-A1 HETEROCYCLIC COMPOUND FUJISAWA PHARMACEUTICAL CO., LTD. (JP) 1997-05-21 EP disclosed